28.05.2013
- AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The...
30.05.2012
- Norway's Pronova BioPharma , which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies. The victory over...
